Cue Biopharma, Inc. (CUE)
Market Closed
16 Oct, 08:00 PM
$
16. 71
-1.96
-10.4981%
$
200.93M Market Cap
- P/E Ratio
- Div Yield
105,195 Volume
- Eps
$ 18.67
Previous Close Investors:
Want to track CUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cue Biopharma, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Didric Cederholm Lion Point Capital LP | 52,928 | $1.35M | $899,384.33 | -$452,396.79 | -33.47% |
 Richard Slavik Newbridge Financial Services Group Inc. | 99 | $2,528.46 | $1,848.33 | -$680.13 | -26.9% |
 Tyler Glazier New Millennium Group LLC | 189.75 | $1,753.67 | $3,322.14 | $1,568.47 | 89.44% |
 Edward Lowndes Angeles Wealth Management LLC | 7,000 | $178,780 | $122,780 | -$56,000 | -31.32% |
 Kevin Roan Stempoint Capita LLP | 66,995 | $1.71M | $1.23M | -$484,373.85 | -28.31% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 1 | $25.54 | $18.67 | -$6.87 | -26.9% |
 Joshua Stipcich Tidemark, LLC | 50 | $357.78 | $897.75 | $539.97 | 150.92% |
 Zachary Canonico DIADEMA PARTNERS LP | 48,369 | $1.24M | $882,008.71 | -$353,335.55 | -28.6% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 12,332 | $314,959.28 | $215,686.68 | -$99,272.6 | -31.52% |
2026 © Marketlog. All Rights Reserved.
